Miguel Regueiro, MD

Miguel Regueiro, M.D., is currently Chief of the Digestive Disease Institute (DDI) at Cleveland Clinic. He holds the inaugural Melody and Steve Golding Chair for Digestive Diseases. Prior to his role as Chief of DDI, he was the Chair of the Department of Gastroenterology, Hepatology, and Nutrition.

Dr. Regueiro earned his bachelor’s degree at the University of Pennsylvania and his medical degree at Drexel (Hahnemann) University. He completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School’s Beth Israel Hospital.

Dr. Regueiro was Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh School of Medicine from 2000 to 2018. There, he served as the IBD Clinical Medical Director, Senior Medical Lead of Specialty Medical Homes, was Professor with Tenure, and in 2018 was honored as the UPMC Endowed Chair for Patient Centered Care in Inflammatory Bowel Diseases.

Dr. Regueiro has received several honors, including the inaugural Melody and Steve Golding Chair for Digestive Diseases and an endowed chair in Gastroenterology and Hepatology at Cleveland Clinic.

He received the Endowed Chair of Patient Centered Care at UPMC, the Alpha Omega Alpha Honor Society, the Joan Kormblum Memorial Prize for Excellence in Internal Medicine, the Clinical Investigator Training Award from Harvard/MIT Health Sciences, the Crohn’s Colitis Foundation of America Physician of the Year, the National Research Excellence in GI Disease Award, Best Doctors in America, Top Doctor in Pittsburgh, Top Doctor in Cleveland and is an IBD section author for UpToDate. He has also received numerous fellowship teaching awards, and American Gastroenterology Association, American College of Gastroenterology and American College of Physician Fellowships. He serves as the Co-Chair for the annual Advances in Inflammatory Bowel Disease course and inaugural Editor-in-Chief for the innovative Crohn’s and Colitis 360 (digital) journal, 2017 to 2025.

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-03-20, Dr. Regueiro has reported the financial relationships with the companies listed below.

Consulting and/or Speaking. Dr. Regueiro receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Eli Lilly and Company
• Johnson & Johnson
• AbbVie, Inc.
• Takeda Pharmaceuticals North America, Inc.
• Pfizer, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.